article :
Cornu C, Nony P (2011)
Women Were Included Twice in a Meta-Analysis, THE AMERICAN JOURNAL of MEDICINE, vol. pp.1-1
Marchant I, Nony P, Cucherat M, Boissel J-P, Thomas SR, Bejan-Angoulvant T, Laugerotte A, Kahoul R, Gueyffier F (2011)
The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies, PLoS ONE, vol. 6(3) pp.1-7
Bajard A, Chabaud S, Pérol D, Boissel J-P, Nony P (2009)
Revisiting the level of evidence in randomized controlled clinical trials: A simulation approach, Contemporary Clinical Trials, vol. 30(5) pp.400-410
Marchant I, Boissel J-P, Kassaï B, Bejan-Angoulvant T, Massol J, Vidal C, Amsallem E, Naudin F, Galan P, Czernichow S, Nony P, Gueyffier F (2009)
SCORE should be preferred to Framingham to predict cardiovascular death in French population, European Journal of cardiovascular prevention & rehabilitation, vol. 16(5) pp.609-615
Wang H, Boissel J-P, Nony P (2009)
Revisiting the relationship between baseline risk and risk under treatment, Emerging Themes in Epidemiology, vol. 6(1) pp.3451-3459
Amsallem E, Kasparian C, Cucherat M, Chabaud S, Haugh MC, Boissel J-P, Nony P (2007)
Evaluation of two evidence-based knowledge transfer interventions for physicians. A cluster randomized controlled factorial design trial: the CardioDAS study, Fundamental & Clinical Pharmacology, vol. 21 pp.631-641
Mercier C, Boissel J-P, Estève J, Iwaz J, Nony P (2007)
New tools to measure discrepancy between prescribing practices and guideline recommendations, Journal of Evaluation In Clinical Practice, vol. 13 pp.639-646
Skilton MR, Moulin P, Sérusclat A, Nony P, Bonnet F (2007)
A comparison of the NCEP-ATPIII IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: Evidence for sex-specific differences, Atherosclerosis, vol. 190 pp.416-422
Blesius A, Chabaud S, Cucherat M, Mismetti P, Boissel J-P, Nony P (2006)
Compliance-Guided Therapy: A New Insight Into the Potential Role of Clinical Pharmacologists, Clinical Pharmacokinetics, vol. 45 pp.95-104
Amsallem E, Kasparian C, Haddour G, Boissel J-P, Nony P (2005)
Phosphodiesterase III inhibitors for heart failure, Cochrane Database of Systematic Reviews, vol. CD002230 pp.631-641
Boissel J-P, Cucherat M, Nony P , Dronne MA, Kassaï B, Chabaud S (2005)
Modélisation numérique et simulation : nouvelles applications en pharmacologie, Thérapie, vol. 60 pp.1-15
Boissel J-P, Nony P, Amsallem E, Mercier C, Estève J, Cucherat M (2005)
How to measure non-consistency of medical practices with available evidence in therapeutics: a methodological framework, Fundamental & Clinical Pharmacology, vol. 19 pp.591-596
Bonnet F, Irving K, Terra JL, Nony P, Berthezène F, Moulin P (2005)
Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease, Atherosclerosis, vol. 178 pp.339-344
Bonnet F, Irving K, Terra JL, Nony P, Berthezène F, Moulin P (2005)
Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome, Journal of Hypertension, vol. 23 pp.611-617
Boissel J-P, Haugh M, Fardeheb M, Nony P, Gueyffier F, Strang N (2003)
How should therapeutic information be transferred to users?, Fundamental & Clinical Pharmacology, vol. 17 pp.495-503
